The 9th International RASopathies Symposium

Area of Science:

• Genetics and Molecular Biology
• Developmental Biology
• Clinical Medicine

Background:

• RASopathies encompass a group of congenital disorders characterized by overlapping clinical features.
• These disorders stem from germline or early somatic variants leading to hyperactivation of the RAS/mitogen-activated protein kinase (MAPK) signaling pathway.
• The heterogeneous nature of RASopathies necessitates multidisciplinary management and robust scientific research for effective patient care.

Purpose of the Study:

• To summarize key findings and advancements presented at the 9th International RASopathies Symposium.
• To highlight the importance of community collaboration in addressing knowledge gaps and improving patient outcomes.
• To foster the translation of scientific discoveries into clinical treatments for RASopathies.

Main Methods:

• The 9th International RASopathies Symposium convened scientists, clinicians, industry representatives, patients, and family advocates.
• Sessions were structured around organ systems, incorporating patient perspectives to underscore disease burden.
• Discussions focused on recent discoveries, case studies, preclinical research, knowledge gaps, and innovative clinical approaches.

Main Results:

• The symposium showcased recent scientific discoveries and preclinical research advancements in RASopathies.
• Innovative clinical approaches and patient-reported experiences were shared, offering valuable insights.
• The event facilitated discussions on identifying and addressing knowledge gaps in RASopathy research and care.

Conclusions:

• The International RASopathies Symposia are crucial for fostering sustained community collaboration.
• These meetings accelerate the translation of research discoveries into effective treatments for individuals with RASopathies.
• Enhanced collaboration among diverse stakeholders is essential for improving patient health and advancing care for RASopathies.